ISL1基因错义突变(E283D)与2型糖尿病发病相关
研究在一个早发2型糖尿病家系中通过全外显子测序发现ISL1E283D突变(c.849A>T),并构建Isl1E283D敲入小鼠模型。该突变小鼠出现糖耐量受损和葡萄糖刺激的胰岛素分泌受损,胰岛中Ins2及ISL1靶基因表达下调。ISL1E283D对Ins2的转录活性降低59.3%,在INS-1细胞中过表达时导致Ins2表达明显下调。
要点
- 早发2型糖尿病家系中发现ISL1E283D错义突变(c.849A>T)。
- Isl1E283D敲入小鼠出现糖耐量受损和葡萄糖刺激的胰岛素分泌受损。
- ISL1E283D对Ins2转录活性降低59.3%,并下调Ins2及靶基因表达。
核心结论
- ISL1E283D突变通过调控胰岛素及其他靶基因(如NeuroD1)减少胰岛素表达和分泌,导致敲入小鼠出现糖耐量受损,重现人类糖尿病表型;该突变被确定为2型糖尿病的新致病因素,靶向转录因子ISL1或可为人类2型糖尿病精准治疗提供新途径。
研究设计与样本
- 研究对一个早发2型糖尿病家系进行全外显子测序鉴定ISL1E283D突变(c.849A>T),并构建Isl1E283D敲入小鼠模型。
- 对敲入小鼠进行腹腔注射葡萄糖耐量试验(IPGTT)和腹腔注射胰岛素耐量试验(IPITT),在分离的胰岛中评估葡萄糖刺激的胰岛素分泌(GSIS)及Ins2等基因表达。
- 采用细胞荧光素酶报告基因试验和电泳迁移率变动分析评估ISL1E283D转录活性,并在大鼠INS-1细胞中过表达Isl1野生型(Isl1WT)和Isl1E283D,用RT-PCR和蛋白质印迹检测Ins2表达水平。
主要发现
- Isl1E283D敲入小鼠出现葡萄糖刺激的胰岛素分泌受损和血糖水平升高。
- 在分离的胰岛中,Ins2及ISL1其他靶基因Mafa、Pdx1、Slc2a2和相互作用蛋白NeuroD1表达下调。
- ISL1E283D对Ins2的转录活性降低59.3%,在INS-1细胞中过表达时导致Ins2表达明显下调,而过表达Isl1WT导致Ins2表达上调。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Mutations in Isl1, encoding the insulin enhancer-binding protein islet-1 (ISL1), may contribute to attenuated insulin secretion in type 2 diabetes mellitus. We made an Isl1E283D mouse model to investigate the disease-causing mechanism of diabetes mellitus. METHODS: The ISL1E283D mutation (c. 849A>T) was identified by whole exome sequencing on an early-onset type 2 diabetes family and then the Isl1E283D knockin (KI) mouse model was created and an IPGTT and IPITT were conducted. Glucose-stimulated insulin secretion (GSIS), expression of Ins2 and other ISL1 target genes and interacting proteins were evaluated in isolated pancreas islets. Transcriptional activity of Isl1E283D was evaluated by cell-based luciferase reporter assay and electrophoretic mobility shift assay, and the expression levels of Ins2 driven by Isl1 wild-type (Isl1WT) and Isl1E283D mutation in rat INS-1 cells were determined by RT-PCR and western blotting. RESULTS: Impaired GSIS and elevated glucose level were observed in Isl1E283D KI mice while expression of Ins2 and other ISL1 target genes Mafa, Pdx1, Slc2a2 and the interacting protein NeuroD1 were downregulated in isolated islets. Transcriptional activity of the Isl1E283D mutation for Ins2 was reduced by 59.3%, and resulted in a marked downregulation of Ins2 expression when it was overexpressed in INS-1 cells, while overexpression of Isl1WT led to an upregulation of Ins2 expression. CONCLUSIONS/INTERPRETATION: Isl1E283D mutation reduces insulin expression and secretion by regulating insulin and other target genes, as well as its interacting proteins such as NeuroD1, leading to the development of glucose intolerance in the KI mice, which recapitulated the human diabetic phenotype. This study identified and highlighted the Isl1E283D mutation as a novel causative factor for type 2 diabetes, and suggested that targeting transcription factor ISL1 could offer an innovative avenue for the precise treatment of human type 2 diabetes.
引用
- Zhang J, Zhang R, Liu C, et al. Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes. Diabetologia. 2024. PMID: 38819467. doi:10.1007/s00125-024-06186-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。